Vir Biotechnology (VIR) Treasury Shares (2018 - 2025)

Vir Biotechnology (VIR) has 8 years of Treasury Shares data on file, last reported at $5.7 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 14.23% year-over-year to $5.7 million; the trailing twelve-month figure through Dec 2025 stood at $5.7 million (up 14.23% YoY), and the FY2025 full-year result was $5.7 million, up 14.23% from the prior year.
• Treasury Shares rose to $5.7 million in Q4 2025, from $5.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.7 million in Q4 2025 to a low of $36298.0 in Q1 2021.
• A 5-year average of $2.9 million and a median of $2.7 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares tumbled 97.51% in 2021 and surged 7452.44% in 2022, its largest moves.
• Tracing VIR's Treasury Shares over 5 years: stood at $1.3 million in 2021, then soared by 109.84% to $2.7 million in 2022, then jumped by 80.11% to $4.8 million in 2023, then increased by 3.67% to $5.0 million in 2024, then increased by 14.23% to $5.7 million in 2025.
• Business Quant data shows VIR's Treasury Shares at $5.7 million in Q4 2025, $5.0 million in Q4 2024, and $4.8 million in Q4 2023.